Practice guideline of evidence-based medicine : Preferred Reporting Items for Systematic Reviews and Meta-analyses (the PRISMA statement)

DOI Web Site BIBCODE 2 Citations 8 References
  • TAKU Kyoko
    Section of Biostatistical Research, Center for International Collaboration and Partnership, National Institute of Health and Nutrition
  • YOSHIDA Yoshitoku
    Department of Health and Social Sciences, Nagoya University Graduate School of Medicine
  • OMORI Toyonori
    Department of Health Care Policy and Management, Nagoya City University Graduate School of Medical Sciences

Bibliographic Information

Other Title
  • エビデンスに基づく医療（ＥＢＭ）の実践ガイドライン　システマティックレビューおよびメタアナリシスのための優先的報告項目（ＰＲＩＳＭＡ声明）
  • エビデンス ニ モトズク イリョウ EBM ノ ジッセン ガイドライン システマティックレビュー オヨビ メタアナリシス ノ タメ ノ ユウセンテキ ホウコク コウモク PRISMA セイメイ

Search this article

Description

Systematic reviews and meta-analyses have become increasingly important in health care, especially in the field of evidence-based medicine (EBM). They are also now conducted to investigate diagnostic or prognostic questions, policy making, etc. Several early studies evaluated the quality of review reports, but the results were generally poor. In 1996, to address the suboptimal reporting of meta-analyses, an international group developed a guidance called the QUOROM statement (The Quality of Reporting of Meta-analyses), which focused on the reporting of meta-analyses of randomized controlled trials. In 2009, the managing committee has developed a revision of QUOROM, renamed PRISMA statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), which have been updated to address several conceptual and practical advances in the science of systematic reviews. In this article, we summarized and explained the new PRISMA statement on the basis of our experience of having conducted systematic reviews and meta-analyses.

Journal

Citations (2)*help

See more

References(8)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top